Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma

Pediatric Dermatology

Volumn 27, Issue 3, 2010, Pages 322-323

  Greene, Arin K ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ORAPRED; PREDNISOLONE; PROPRANOLOL; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENAL INSUFFICIENCY; ASEPTIC NECROSIS; BRADYCARDIA; CATARACT; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; GLAUCOMA; HEMANGIOMA; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFANTILE HEMANGIOMA; LONG TERM CARE; MOON FACE; MORBIDITY; MYOPATHY; NOTE; OSTEOPOROSIS; PATIENT COMPLIANCE; PERSONALITY DISORDER; PRIORITY JOURNAL; STOMACH IRRITATION; TREATMENT RESPONSE; INFANT; NEWBORN; SKIN NEOPLASMS;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-ANTAGONISTS; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; PROPRANOLOL; SKIN NEOPLASMS;

EID: 77952748680     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2010.01157.x     Document Type: Note

References (15)

1. Leaute-Labreze C, Dumas de la Roque E, Hubiche T et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008 358 : 2649 2651.
2. Sans V, Dumas de la Roque E, Berge J et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009 124 : 423 431.
3. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009 26 : 610 614.
4. Frieden IL, Drolet BA. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol 2009 26 : 642 644.
5. Zarem HA, Edgerton MT. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 1967 39 : 76 83.
6. Bennett ML, Fleischer AB, Chamlin SL et al. Oral corticosteroid use is effective for cutaneous hemangiomas. Arch Dermatol 2001 137 : 1208 1213.
7. Chang LC, Haggstrom AN, Drolet BA et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008 122 : 360 367.
8. Greene AK, Rogers G, Mulliken JB. Management of parotid hemangioma in 100 children. Plast Reconstr Surg 2004 113 : 53 67.
9. Seale JP, Compton MR. Side-effects of corticosteroid agents. Med J Aust 1986 144 : 139 142.
10. Fardet L, Abdulrhaman K, Cabane J et al. Corticosteroid-induced adverse events in adults. Drug Saf 2007 30 : 861 881.
11. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangiomas. Plast Reconstr Surg 1999 104 : 1616 1623.
12. George ME, Sharma V, Jacobson J et al. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004 140 : 963 969.
13. Lomenick JP, Backeljauw PF, Lucky AW. Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas - a retrospective study. Pediatr Dermatol 2006 23 : 169 174.
14. Lomenick JP, Reifschneider KL, Lucky AW et al. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol 2009 145 : 262 266.
15. Greene AK. Corticosteroid treatment for problematic infantile hemangioma: evidence does not support an increased risk for cerebral palsy. Pediatrics 2008 126 : 1251 1252.